(2S,3S,4S,5R,6S)-6-((5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid

Basic Information

View in Editor

CAS Number

22688-78-4

Molecular Formula

C21H18O12

Molecular Weight

462.36 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

Physical State

Yellow powder

Solubility

Methanol; DMSO

SMILES

View in Editor

C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)C(=O)O)O)O)O)O

InChI

InChI=1S/C21H18O12/c22-8-3-1-7(2-4-8)17-18(13(25)12-10(24)5-9(23)6-11(12)31-17)32-21-16(28)14(26)15(27)19(33-21)20(29)30/h1-6,14-16,19,21-24,26-28H,(H,29,30)/t14-,15-,16+,19-,21+/m0/s1

InChIKey

FNTJVYCFNVUBOL-ZUGPOPFOSA-N

LogP

-0.1522000000000004

Topological Polar Surface Area

207.34999999999997 Å²

Hydrogen Bond Donor/Acceptor

7 / 12

Complexity

790

Safety Information

View Safety Information

Storage Conditions

2-8℃

Synonyms & References

English

ACon1_000499
Kaempferol 3-O-
CS-0103798
beta-D-Glucopyranosiduronic acid, 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-3-yl
AKOS032946053
kaempferol glucuronide
5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl beta-D-glucopyranosiduronic acid
(2S,3S,4S,5R,6S)-6-((5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
kaempferol 3-O-beta-D-glucoronopyranoside
Kaempferol 3-O-beta-D-glucuronide, >=97.0% (HPLC)
Kaempferol3-glucuronide
Kaempferol 3-O-??-D-glucuronide
BRD-K13548766-001-01-0
Kaempferol 3-glucuronide
A-D-glucuronide
kaempferol 3-O-beta-D-glucopyranosiduronic acid
Kaempherol 3-O-beta-glucuronide
Kaempferol-3-beta-O-glucuronide
Kaempferol 3-O-beta-D-glucuronopyranoside
MEGxp0_000322
EGG5MC7LNS
Kaempferol 3-O-glucuronide
Kaempferol 3-beta-glucuronide
Kaempferol-O-glucuronide
Kaempferol 3-O-beta-D-glucuronide
Glucopyranosiduronic acid, 5,7-dihydroxy-2-(p-hydroxyphenyl)-4-oxo-4H-1-benzopyran-3-yl, beta-D-
SCHEMBL1280014
MS-28488
HY-N7176
DTXSID90415745
22688-78-4

MDL Number

MFCD04039813

FAQ

What regulatory guidelines apply to (2S,3S,4S,5R,6S)-6-((5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (CAS: 22688-78-4)?

The regulatory guidelines for (2S,3S,4S,5R,6S)-6-((5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (CAS: 22688-78-4) include REACH regulations covering environmental, health, and safety aspects. Additionally, FDA and EPA guidelines may apply due to its potential use in pharmaceuticals and environmental applications. Proper handling, storage, and disposal should comply with local and international regulations.

Are there alternatives to (2S,3S,4S,5R,6S)-6-((5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid in synthesis?

There are several alternatives to (2S,3S,4S,5R,6S)-6-((5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid in synthesis. Common alternatives include related chroman-3-ol derivatives and similar cyclic polyhydroxy compounds. These can be synthesized using different reagents and conditions, providing flexibility in chemical synthesis.

What is the market or research trend for (2S,3S,4S,5R,6S)-6-((5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (CAS: 22688-78-4)?

The market trend for (2S,3S,4S,5R,6S)-6-((5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (CAS: 22688-78-4) shows increasing interest in its use in pharmaceuticals and natural product chemistry. Research trends focus on its potential biological activities and applications in drug discovery. Market demand is driven by its unique chemical structure and pharmaceutical properties.

How should waste containing (2S,3S,4S,5R,6S)-6-((5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (CAS: 22688-78-4) be handled?

Waste containing (2S,3S,4S,5R,6S)-6-((5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid (CAS: 22688-78-4) should be collected in appropriate containers and stored under controlled conditions to prevent degradation and environmental release. Waste should be disposed of through incineration or professional waste disposal services. Environmental protection measures must be adhered to, including proper labeling and documentation of waste management practices.